AstraZeneca expects performance boost in second half after posting 15% quarterly revenue jumpProactive Investors • 04/30/21
AstraZeneca to show there is more to the company than the COVID-19 vaccineProactive Investors • 04/29/21
Coronavirus: One vaccine dose enough to cut transmission risk by half, AstraZeneca/EU legal challenge beginsProactive Investors • 04/28/21
Arix Bioscience investee LogicBio signs strategic collaboration with CANBridge PharmaProactive Investors • 04/27/21
LogicBio Therapeutics, CANbridge Ink Partnership For Development Of Gene Therapy CandidatesBenzinga • 04/27/21
CANbridge Pharmaceuticals Announces Strategic Collaboration with LogicBio Therapeutics and Licenses to Gene Delivery and Editing PlatformsBusiness Wire • 04/27/21